1,905,252 Shares in Core Scientific, Inc. $CORZ Acquired by DSC Meridian Capital LP

DSC Meridian Capital LP acquired a new position in shares of Core Scientific, Inc. (NASDAQ:CORZ) during the 2nd quarter, Holdings Channel.com reports. The firm acquired 1,905,252 shares of the company’s stock, valued at approximately $48,755,000. Core Scientific accounts for 11.4% of DSC Meridian Capital LP’s holdings, making the stock its 3rd largest position.

Other institutional investors and hedge funds have also bought and sold shares of the company. Xponance LLC grew its position in shares of Core Scientific by 2.5% during the 4th quarter. Xponance LLC now owns 22,896 shares of the company’s stock worth $333,000 after buying an additional 562 shares in the last quarter. Handelsbanken Fonder AB raised its holdings in shares of Core Scientific by 0.7% in the second quarter. Handelsbanken Fonder AB now owns 94,500 shares of the company’s stock valued at $2,418,000 after acquiring an additional 700 shares in the last quarter. Orion Porfolio Solutions LLC lifted its stake in Core Scientific by 5.2% in the third quarter. Orion Porfolio Solutions LLC now owns 15,539 shares of the company’s stock worth $279,000 after acquiring an additional 766 shares during the period. GAMMA Investing LLC grew its holdings in Core Scientific by 34.5% during the 2nd quarter. GAMMA Investing LLC now owns 3,049 shares of the company’s stock worth $78,000 after acquiring an additional 782 shares in the last quarter. Finally, Bank of Montreal Can increased its position in Core Scientific by 4.2% during the 4th quarter. Bank of Montreal Can now owns 21,592 shares of the company’s stock valued at $314,000 after purchasing an additional 869 shares during the period.

Insider Transactions at Core Scientific

In other Core Scientific news, Director Elizabeth Crain bought 6,000 shares of Core Scientific stock in a transaction that occurred on Thursday, August 20th. The shares were bought at an average cost of $18.33 per share, with a total value of $109,980.00. Following the transaction, the director directly owned 71,348 shares of the company’s stock, valued at approximately $1,307,808.84. This represents a 9.18% increase in their position. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through this link. Also, Director Eric Stanton Weiss purchased 7,000 shares of the firm’s stock in a transaction on Tuesday, August 18th. The stock was acquired at an average price of $19.19 per share, with a total value of $134,330.00. Following the completion of the purchase, the director owned 259,262 shares of the company’s stock, valued at $4,975,237.78. The trade was a 2.77% increase in their position. The disclosure for this purchase is available in the SEC filing. Insiders sold 90,000 shares of company stock valued at $2,185,800 in the last quarter. 1.70% of the stock is currently owned by corporate insiders.

Core Scientific Stock Down 3.0%

NASDAQ CORZ opened at $17.27 on Tuesday. The firm has a market cap of $5.55 billion, a PE ratio of -3.91 and a beta of 5.59. The company has a 50 day moving average price of $22.75 and a 200 day moving average price of $21.01. Core Scientific, Inc. has a 52 week low of $13.14 and a 52 week high of $30.46.

Core Scientific (NASDAQ:CORZ) last announced its earnings results on Tuesday, July 28th. The company reported ($3.32) earnings per share for the quarter, missing the consensus estimate of ($0.06) by ($3.26). The business had revenue of $164.20 million for the quarter, compared to the consensus estimate of $144.83 million. On average, equities research analysts anticipate that Core Scientific, Inc. will post -1.36 earnings per share for the current fiscal year.

Analyst Ratings Changes

A number of research firms have recently issued reports on CORZ. Jefferies Financial Group increased their price objective on shares of Core Scientific from $24.00 to $37.00 and gave the company a “buy” rating in a research note on Thursday, May 14th. Sanford C. Bernstein restated an “outperform” rating and set a $32.00 target price on shares of Core Scientific in a report on Wednesday, June 3rd. Freedom Capital raised Core Scientific from a “hold” rating to a “strong-buy” rating in a research report on Thursday, July 30th. Weiss Ratings reiterated a “sell (d-)” rating on shares of Core Scientific in a report on Friday, July 17th. Finally, Capital One Financial set a $33.00 price target on Core Scientific in a research report on Thursday, July 30th. Two equities research analysts have rated the stock with a Strong Buy rating, sixteen have assigned a Buy rating, one has given a Hold rating and one has given a Sell rating to the company’s stock. According to MarketBeat.com, the company has an average rating of “Moderate Buy” and a consensus target price of $32.18.

Core Scientific Company Profile

Core Scientific, Inc (NASDAQ: CORZ) is a leading provider of large-scale blockchain infrastructure and digital asset mining services. The company develops, owns and operates high-performance data centers optimized for the mining of Bitcoin and other proof-of-work cryptocurrencies. In addition to its core mining operations, Core Scientific offers colocation, hosting and managed services designed to support institutional clients and enterprise users in deploying and scaling blockchain nodes and computing hardware.

Core Scientific’s service portfolio includes hardware procurement, deployment and maintenance, real-time monitoring, power management and network connectivity.